Through downregulation of GSK3B, CTNNB1, SNAI2, and CDH2, CLDN3 could significantly suppress metastasis by inactivating the Wnt/β-catenin-EMT axis in HCC cells (48). The gene discussed is CLDN3; the disease is hepatocellular carcinoma.